SIRT2 and apparent mineralocorticoid excess: In summary, our study indicated that APE rats treated with simvastatin can effectively reduce mPAP and RVSP, alleviate hypoxemia and inflammation, via enhancement of SIRT2 and inhibition of NF-κB, thus providing a new idea for the clinical treatment of APE.